Delivery Order SPE2DB20D3103-SPE2DB22FM9M4
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $6,265.44, is for the delivery of Ciproflox-Dexameth Otic Suspension (7.5 ml) to support military healthcare programs. The award, which has a completion date of April 12, 2022, is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $2,160.98 delivery order issued by the Defense Logistics Agency (DLA) for the supply of Ciproflox-Dexameth Otic Suspension (7.5ml). The award, with a completion date of January 11, 2023, is a firm fixed-price contract without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $3,140.36, is for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, with a performance period ending on July 26, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,266.86 firm fixed-price delivery order is for Ciproflox-Dexameth Otic Suspension, a pharmaceutical product. The award is not designated under any set-aside program. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product. The contract has a ceiling value of $1,105.36 and runs through June 13, 2023. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,535.14 firm fixed-price delivery order is for the supply of the medication Ciproflox-Dexameth Otic Suspension, with a period of performance through August 7, 2024. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including the medication Ciproflox-Dexameth Otic Suspension. The contract has a ceiling value of $1,536.62 and an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,454.07 firm fixed-price delivery order is for Ciproflox-Dexameth Otic Suspension, a medical product used in the treatment of various conditions. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,030.20 firm fixed-price delivery order is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has an ultimate completion date of October 11, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract provides for the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes and vials, to support military...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FM9M4Delivery Order
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,265.17 Firm Fixed Price Delivery Order covers the supply of Ciproflox-Dexameth Otic Suspension, a pharmaceutical product, with a completion date of March 10, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is not designated with a set-aside requirement, indicating full and open competition. The contract aligns with the DLA's role in providing essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to the Department of Defense and other federal healthcare agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 3/9/22 |